Ovoca Bio Share Discussion Threads

[mickinvest] 11/8/2021 11:01

Article from Monday.

“Approximately 4 million women seeking treatment in the U.S., with similar prevalence estimates in Europe,” Christopher Wiltshire, chief business officer at Ovoca Bio, told BioSpace, via email.

If it is approved, it will be available through prescription in most major markets.

[clocktower] 11/8/2021 09:04

With one MM on bid, I guess they are trying to pick up stock for a larger buyer, so we may well see it off and running before long if any weak holders are thinking of moving on.

[ny boy] 11/8/2021 08:28

Patience required here, not for short term speculators using borrowed monies.

Will have a look back later in the year on progress GLA long term holders.

[dave4545] 10/8/2021 12:09

Imagine selling for around 12p and then it issues very positive data and goes to 120p

Surely it's worth the gamble here to hold but tell that to day traders.

[jibba jabber] 10/8/2021 12:08

P/D or a leak?

[dave4545] 10/8/2021 12:07

Was not aware of any article ?

[fillipe] 10/8/2021 12:06

Mmmm ...looks like the rise is on the back of the Mail article.
A pity it appears being so quickly sold into.

f

[fillipe] 10/8/2021 11:55

Exciting being the operative word!

Good to see the overall general interest in this product area.

f

[roberts1975] 10/8/2021 10:51

Looks like an attempt at a quick p n d

[clocktower] 10/8/2021 10:22

Already the second top rising stock.

Exciting trading times ahead imo.

[dave4545] 10/8/2021 09:59

12p full offer wanted online

Held too long to be selling on a 10%+ rise even if the overall markets are rubbish

Shame others are

[clocktower] 10/8/2021 09:51

Looks like it might be on a bull run again.

If it works there will be cases in courts of partners having mixed a pill in with food being jailed for drug misuse. Think of the humour in court when asked about the effects of the drug upon the complainant.

[jimtech] 04/8/2021 18:30

Thanks, Hedge! Appreciate it. I have read what I can find and have made a couple of small purchases. Unusual to find a company that seems to have such obvious potential but very little written about it.
Back in the 90s (!) I knew someone who worked for a pharmaceutical company and she told me how hilarious it was that they were developing a treatment for Angina that had an unexpected side effect of arousing the males that were testing it. I had a good laugh then forgot all about it until the company launched the drug as Viagra. Opportunity missed!

[hedgehog 100] 04/8/2021 18:05

Last summer was a period of excellent OVB share price performance, starting with its final results, as investors anticipated Russian marketing approval, and the same should apply this time too.

Ultimately approval last year was temporarily knocked back, but only for minor procedural 'box-ticking' stuff.
Crucially, there were no concerns raised about the drug's effectiveness or safety, which are the two key criteria:

02/10/2020 07:00 UK Regulatory (RNS & others) Ovoca Bio PLC Update re Russian Marketing Authorisation
" ... Ovoca has been informed that the Minzdrav has not granted the MA to BP-101 following the identification of certain issues relating to the chemistry, manufacturing and controls (CMC) and labelling sections of the MA submission dossier. The Company notes that no issues were highlighted by the Minzdrav regarding the safety or efficacy of BP-101 in the acquired generalized form of HSDD, which has been established by clinical data from two Phase 1 studies, a Phase 2a study and the pivotal Phase 3 study completed in 2019, all as conducted in the Russian Federation. ..."


So approval this time round looks like a formality, and it could be as early as October.

[hedgehog 100] 04/8/2021 17:25

Jim,

I think there's a fairly narrow window of opportunity to buy in at about the current levels.

Russian marketing approval is expected in October-December, and savvy investors will likely be buying in ahead of that in anticipation ... with some leeway, to 'beat the rush'.

And with an illiquid share like this, it can take quite some time - perhaps even weeks - to accumulate a decent stake, as you wait for sales to become available.

[hedgehog 100] 04/8/2021 17:08

Jim,

The company doesn't appear to have any research reports on it at the moment, or promotion, which helps to explain why it's so lowly-valued.

The company doesn't need to promote itself at the moment because it doesn't need to raise money.

So it's saving money and time on non-essential reports and RNSes, to concentrate on developing it's business.

To me, this is 'reassuringly non-hypey'.

And you don't need to be a weatherman to know which way the wind blows: investment can sometimes be very simple.

It's clear in this case that there is a vast unmet need for OVB's treatment, that it works, and that it is safe.

Moreover, Russian marketing approval is expected in October-December.

That should give an immediate big boost to the s.p., and should be followed by news on this:
"Discussions are progressing with a leading local candidate that can both manufacture and distribute BP-101."

Sales should then commence in Russia, the world's largest country, providing great cashflow to complement OVB's already excellent balance sheet.

And we also have the results of the Australia and New Zealand trials to look forward to relatively soon, a major step on the road to opening up other markets, including Europe and the US.

[dave4545] 04/8/2021 12:21

Yep, do not chase up a price in this market, might as well wait and see if anybody sells back to the mm's they normally do atm.

[jimtech] 04/8/2021 11:48

Thanks. Have read up on OVB history so understand the POLY link. I have made a couple of purchases. Trouble is the volume is so low that each time I buy I make the share price go up making it more expensive for me to buy further!

[imastu pidgitaswell] 04/8/2021 11:33

It's a historical legacy - basically they used to be in a different business and just use the quoted vehicle for the activity they now do.

That former business had a stake in POLY, which is effectively used for funding - every so often they sell down a chunk of the stake for cash, which they use to fund their costs - until they are (or are not) able to earn some income.

An interesting form of financing, basically.

Had a look a year or more ago, because of curiosity about the stake as I have a large investment in POLY myself - and had a good discussion with dave - but biotech not really my thing.

[dave4545] 04/8/2021 11:22

I used to check it regularly but it's been around £15 levels and nobody really knows how many they have left now if any at all.

Total mystery until they update.

[mickinvest] 04/8/2021 08:26

I'd recommend getting a "friend and her mates" in Oz or NZ on the trial, life changing bet if it "comes good"

[dave4545] 04/8/2021 07:31

Well that's Ovb

I've been holding 2 years now.

PR rubbish, updates thin on the ground

Just used to it.

Shares did double+ from lows in this time so I did make some money by selling a few at 18p and buying back around 10p but apart from that I've been stuck with the rest for years now.